CP55,667 Inhibitor

MBS5756168 is an inhibitor targeting CP55,667. CP55,667 is an antagonist of CB2-selective.

Chuchawankul S, Shima M, Buckley NE, Hartmann CB, McCoy KL. Role of cannabinoid receptors in inhibiting macrophage costimulatory activity. Int Immunopharmacol. 2004 Feb;4(2):265-78. PubMed PMID: 14996418.
Puffenbarger RA, Boothe AC, Cabral GA. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia. 2000 Jan 1;29(1):58-69. PubMed PMID: 10594923.
Burnette-Curley D, Cabral GA. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol. Proc Soc Exp Biol Med. 1995 Oct;210(1):64-76. PubMed PMID: 7675800.
Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther. 1988 Dec;247(3):1046-51. PubMed PMID: 2849657.

Small volumes of CP55,667, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.